Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Adriana Weinberg

Concepts (834)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
100
2026
3048
10.390
 Why?
Herpes Zoster Vaccine
26
2026
154
10.020
 Why?
Herpes Zoster
33
2025
315
9.250
 Why?
Herpesvirus 3, Human
37
2025
333
7.370
 Why?
Influenza Vaccines
29
2021
524
5.930
 Why?
Cytomegalovirus Infections
28
2024
205
5.880
 Why?
Immunity, Cellular
34
2025
273
5.620
 Why?
Antibodies, Viral
44
2024
684
5.230
 Why?
Pregnancy Complications, Infectious
26
2026
420
5.010
 Why?
T-Lymphocytes, Regulatory
15
2025
392
4.700
 Why?
Cytomegalovirus
27
2024
168
4.260
 Why?
Influenza, Human
27
2021
611
3.970
 Why?
Respiratory Syncytial Virus, Human
7
2026
82
3.370
 Why?
Antiretroviral Therapy, Highly Active
22
2017
277
2.810
 Why?
Immunologic Memory
15
2026
375
2.570
 Why?
Anti-HIV Agents
19
2026
864
2.540
 Why?
Influenza A Virus, H1N1 Subtype
13
2021
157
2.530
 Why?
Pneumococcal Infections
4
2022
104
2.510
 Why?
Vaccines, Attenuated
23
2024
130
2.500
 Why?
T-Lymphocyte Subsets
12
2019
421
2.460
 Why?
T-Lymphocytes
22
2020
2041
2.360
 Why?
Leukocytes, Mononuclear
16
2025
580
2.280
 Why?
CD4-Positive T-Lymphocytes
29
2023
1133
2.080
 Why?
Respiratory Tract Infections
7
2025
395
2.050
 Why?
Respiratory Syncytial Virus Infections
3
2026
136
1.990
 Why?
Isoniazid
7
2026
69
1.710
 Why?
Vaccination
23
2024
1414
1.680
 Why?
Chickenpox
8
2024
81
1.620
 Why?
Humans
240
2026
143821
1.590
 Why?
Antiviral Agents
17
2023
743
1.560
 Why?
Latent Tuberculosis
2
2026
70
1.540
 Why?
Chickenpox Vaccine
11
2024
75
1.540
 Why?
Interferon-gamma
20
2022
791
1.530
 Why?
Tuberculosis
7
2026
287
1.510
 Why?
Female
166
2026
77570
1.470
 Why?
Pregnancy
45
2026
7154
1.460
 Why?
Drug Resistance, Viral
14
2017
119
1.430
 Why?
HIV
8
2022
248
1.410
 Why?
Antitubercular Agents
5
2026
213
1.340
 Why?
Virus Diseases
4
2018
217
1.340
 Why?
CD8-Positive T-Lymphocytes
12
2019
945
1.320
 Why?
DNA, Viral
13
2024
361
1.310
 Why?
Infant
43
2026
9885
1.300
 Why?
Tetanus Toxoid
4
2021
34
1.280
 Why?
Mycobacterium tuberculosis
2
2026
333
1.280
 Why?
Virus Shedding
6
2017
48
1.260
 Why?
Infectious Disease Transmission, Vertical
10
2023
185
1.240
 Why?
Adult
102
2026
40129
1.200
 Why?
Influenza A virus
9
2013
112
1.180
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
9
2009
28
1.180
 Why?
Vaccines, Synthetic
8
2026
140
1.170
 Why?
Influenza B virus
9
2017
45
1.160
 Why?
Hepatitis A Vaccines
5
2020
20
1.130
 Why?
Antibodies, Bacterial
5
2022
147
1.120
 Why?
Dermatitis, Atopic
5
2020
330
1.100
 Why?
Male
126
2026
71569
1.090
 Why?
B-Lymphocytes
7
2021
889
1.080
 Why?
Cord Blood Stem Cell Transplantation
3
2023
103
1.070
 Why?
Adjuvants, Immunologic
8
2021
246
1.060
 Why?
CD4 Lymphocyte Count
17
2019
275
1.010
 Why?
HIV-1
13
2019
904
1.000
 Why?
Antibody Formation
7
2023
294
0.990
 Why?
Hemagglutination Inhibition Tests
14
2021
38
0.980
 Why?
Pneumococcal Vaccines
3
2022
129
0.970
 Why?
Anti-Retroviral Agents
8
2023
240
0.960
 Why?
Transforming Growth Factor beta
4
2025
481
0.950
 Why?
Lymphocyte Activation
26
2020
1143
0.950
 Why?
Infant, Newborn
25
2026
6362
0.950
 Why?
Gastrointestinal Microbiome
2
2025
746
0.920
 Why?
Breast Feeding
4
2023
444
0.920
 Why?
Transforming Growth Factor beta1
2
2025
179
0.920
 Why?
Interleukin-2
13
2022
447
0.900
 Why?
Vaccines, Inactivated
10
2017
70
0.880
 Why?
Monocytes
2
2025
543
0.880
 Why?
Respiratory Syncytial Viruses
1
2025
58
0.870
 Why?
Enzyme-Linked Immunospot Assay
6
2018
37
0.870
 Why?
Hematopoietic Stem Cell Transplantation
3
2023
681
0.870
 Why?
Viral Load
18
2023
515
0.860
 Why?
Viremia
9
2021
158
0.850
 Why?
HIV Protease Inhibitors
3
2019
69
0.820
 Why?
Child, Preschool
35
2025
11630
0.800
 Why?
Immune Reconstitution
1
2023
9
0.800
 Why?
Child
54
2025
22440
0.790
 Why?
Epstein-Barr Virus Infections
5
2013
97
0.790
 Why?
Environmental Exposure
2
2018
584
0.760
 Why?
Papillomavirus Vaccines
3
2018
298
0.760
 Why?
Double-Blind Method
18
2026
2017
0.760
 Why?
Herpesvirus 1, Human
3
2016
81
0.730
 Why?
Receptors, Tumor Necrosis Factor
8
2001
166
0.720
 Why?
Adolescent
54
2025
22233
0.710
 Why?
Cytokines
12
2025
2093
0.710
 Why?
Middle Aged
64
2026
35630
0.690
 Why?
Orthomyxoviridae
3
2017
40
0.690
 Why?
Young Adult
30
2026
13914
0.680
 Why?
Polymerase Chain Reaction
12
2023
1057
0.680
 Why?
Aged
43
2026
25615
0.660
 Why?
DNA-Directed DNA Polymerase
4
2008
48
0.650
 Why?
Aged, 80 and over
18
2022
8130
0.640
 Why?
Vitamin D
2
2024
402
0.640
 Why?
Rotavirus Infections
2
2017
35
0.630
 Why?
Rotavirus Vaccines
2
2017
37
0.630
 Why?
Viral Proteins
5
2012
365
0.630
 Why?
Postpartum Period
7
2026
360
0.630
 Why?
Herpesvirus 4, Human
8
2014
173
0.620
 Why?
Immunosuppressive Agents
7
2014
843
0.610
 Why?
Killer Cells, Natural
5
2026
473
0.610
 Why?
Viral Envelope Proteins
2
2021
99
0.590
 Why?
Medroxyprogesterone Acetate
2
2016
37
0.580
 Why?
Respiratory Syncytial Virus Vaccines
1
2019
39
0.580
 Why?
Inflammation
5
2026
2893
0.570
 Why?
RNA, Viral
9
2024
690
0.570
 Why?
Antibodies, Neutralizing
7
2021
344
0.570
 Why?
Paramyxoviridae Infections
2
2011
12
0.560
 Why?
Simplexvirus
9
2016
82
0.560
 Why?
Human papillomavirus 18
1
2018
14
0.560
 Why?
Immunocompromised Host
9
2019
201
0.550
 Why?
Human papillomavirus 16
1
2018
31
0.550
 Why?
Hepatitis A Antibodies
2
2009
3
0.550
 Why?
Cryopreservation
2
2010
110
0.550
 Why?
AIDS-Related Opportunistic Infections
3
2019
129
0.540
 Why?
Th1 Cells
1
2018
142
0.530
 Why?
Lymphocyte Subsets
2
2015
87
0.520
 Why?
Antigens, Viral
8
2017
183
0.520
 Why?
Immunoconjugates
2
2013
132
0.510
 Why?
Flow Cytometry
11
2019
1192
0.510
 Why?
Immunization, Secondary
6
2017
91
0.510
 Why?
Age Factors
9
2019
3288
0.510
 Why?
Hospitalization
6
2021
2340
0.500
 Why?
Immunity, Innate
3
2026
853
0.500
 Why?
Mutation
7
2009
4106
0.500
 Why?
Acyclovir
6
2012
96
0.490
 Why?
Herpesviridae Infections
5
2013
149
0.490
 Why?
Encephalomyelitis, Autoimmune, Experimental
5
1999
66
0.490
 Why?
Premature Birth
2
2019
377
0.480
 Why?
Case-Control Studies
14
2024
3614
0.480
 Why?
Host-Pathogen Interactions
1
2019
372
0.470
 Why?
Immunoglobulin G
8
2026
899
0.470
 Why?
Viral Vaccines
4
2014
108
0.470
 Why?
Herpes Simplex
4
2016
94
0.460
 Why?
T-Lymphocytes, Cytotoxic
3
2011
178
0.450
 Why?
Reagent Kits, Diagnostic
2
2005
35
0.450
 Why?
Central Nervous System Viral Diseases
3
2004
77
0.440
 Why?
Contraceptive Agents, Female
1
2016
80
0.440
 Why?
B-Lymphocyte Subsets
1
2015
80
0.430
 Why?
Immunoassay
5
2017
112
0.430
 Why?
Immunity, Mucosal
2
2012
99
0.420
 Why?
Injections, Intramuscular
4
2017
135
0.420
 Why?
Foscarnet
6
2008
20
0.420
 Why?
Immunophenotyping
6
2019
327
0.400
 Why?
Transplant Recipients
3
2024
180
0.400
 Why?
Antigen-Presenting Cells
4
2022
163
0.390
 Why?
B-Lymphocytes, Regulatory
1
2013
3
0.390
 Why?
Gene Expression Profiling
3
2019
1817
0.390
 Why?
Abatacept
3
2026
56
0.380
 Why?
CD4 Antigens
2
2011
144
0.380
 Why?
Influenza A Virus, H3N2 Subtype
4
2020
49
0.380
 Why?
Reverse Transcriptase Inhibitors
3
2020
87
0.380
 Why?
Staphylococcus aureus
1
2017
449
0.380
 Why?
Immune Tolerance
2
2013
378
0.380
 Why?
Alphapapillomavirus
1
2012
36
0.370
 Why?
Dendritic Cells
2
2026
495
0.370
 Why?
Vaccines, Conjugate
2
2022
60
0.370
 Why?
Candida
3
2010
44
0.360
 Why?
Hepatitis A
1
2012
29
0.360
 Why?
Cell Proliferation
6
2020
2540
0.360
 Why?
Cohort Studies
11
2023
5861
0.360
 Why?
Placebos
5
2017
192
0.360
 Why?
Polysaccharides
2
2022
89
0.360
 Why?
Skin
1
2017
760
0.360
 Why?
CD28 Antigens
3
2009
59
0.350
 Why?
Contraceptive Agents
1
2012
65
0.350
 Why?
Metapneumovirus
1
2011
15
0.350
 Why?
Transplantation
1
2011
33
0.350
 Why?
Herpesvirus 2, Human
2
2012
28
0.340
 Why?
Lymphoproliferative Disorders
1
2011
54
0.340
 Why?
Lymphocyte Count
4
2019
168
0.340
 Why?
Benzoxazines
4
2026
29
0.340
 Why?
T-Lymphocytes, Helper-Inducer
7
1994
135
0.340
 Why?
Immunogenicity, Vaccine
5
2026
35
0.330
 Why?
Blood
2
2009
112
0.330
 Why?
Retrospective Studies
21
2024
16754
0.330
 Why?
Nucleosides
1
2010
25
0.330
 Why?
Pregnancy Outcome
7
2021
466
0.330
 Why?
Drug Therapy, Combination
6
2019
1032
0.330
 Why?
Immunoglobulin A
4
2017
218
0.310
 Why?
Cytosine
3
2008
49
0.310
 Why?
Streptococcus pneumoniae
2
2022
176
0.310
 Why?
Programmed Cell Death 1 Receptor
3
2020
270
0.310
 Why?
Adaptive Immunity
2
2017
170
0.310
 Why?
Glycoproteins
2
2023
357
0.310
 Why?
Nucleotides
1
2010
126
0.310
 Why?
Antidepressive Agents
3
2021
240
0.310
 Why?
Refrigeration
1
2009
12
0.310
 Why?
Membrane Glycoproteins
4
2001
499
0.300
 Why?
Immunity, Humoral
2
2021
119
0.300
 Why?
Enzyme-Linked Immunosorbent Assay
8
2021
856
0.300
 Why?
Follow-Up Studies
16
2024
5316
0.300
 Why?
Organophosphonates
3
2008
96
0.300
 Why?
Astrocytes
1
2011
218
0.300
 Why?
Freezing
1
2009
86
0.290
 Why?
Coculture Techniques
2
2025
250
0.290
 Why?
Cytomegalovirus Retinitis
2
2013
22
0.290
 Why?
Tetanus
2
2009
26
0.290
 Why?
Cyclopropanes
4
2026
80
0.290
 Why?
Alkynes
4
2026
64
0.280
 Why?
Fetal Blood
3
2026
339
0.280
 Why?
Lopinavir
3
2023
28
0.280
 Why?
Interleukin-10
3
2022
311
0.280
 Why?
Time Factors
18
2017
7068
0.280
 Why?
Herpesvirus 7, Human
2
2005
5
0.270
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2008
100
0.270
 Why?
Prospective Studies
14
2024
7900
0.270
 Why?
Herpesvirus 6, Human
2
2005
14
0.270
 Why?
Longitudinal Studies
8
2019
2948
0.270
 Why?
Glioblastoma
1
2011
350
0.270
 Why?
Specimen Handling
1
2009
184
0.260
 Why?
Norgestrel
1
2007
2
0.260
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
991
0.260
 Why?
Interleukins
2
2008
252
0.260
 Why?
Apoptosis
6
2011
2446
0.260
 Why?
Biomarkers
7
2021
4248
0.250
 Why?
Incidence
9
2023
2845
0.250
 Why?
Nucleic Acid Hybridization
2
2006
189
0.250
 Why?
Antigens, CD
5
2017
564
0.240
 Why?
Lung Transplantation
4
2002
336
0.230
 Why?
Coinfection
2
2019
135
0.230
 Why?
Acetates
2
2023
82
0.230
 Why?
Lymphokines
5
1994
130
0.230
 Why?
Fibroblasts
4
2025
1035
0.230
 Why?
Bone Marrow Transplantation
2
2005
294
0.220
 Why?
Ritonavir
2
2016
72
0.220
 Why?
A549 Cells
1
2025
75
0.220
 Why?
Receptors, OX40
8
2001
15
0.220
 Why?
Dexamethasone
1
2007
373
0.220
 Why?
Cell Survival
5
2010
1110
0.220
 Why?
Roseolovirus Infections
1
2004
7
0.220
 Why?
Paramyxoviridae
1
2004
2
0.210
 Why?
Measles Vaccine
1
2024
18
0.210
 Why?
Chemical and Drug Induced Liver Injury
1
2026
138
0.210
 Why?
Virus Replication
5
2017
537
0.210
 Why?
Quinazolines
2
2023
266
0.210
 Why?
BCG Vaccine
2
2023
26
0.210
 Why?
Forkhead Transcription Factors
3
2011
205
0.210
 Why?
RNA, Messenger
10
2011
2847
0.210
 Why?
Ganciclovir
4
2008
53
0.210
 Why?
Milk, Human
2
2023
171
0.210
 Why?
Autoimmune Diseases
3
2014
464
0.200
 Why?
Immunity
2
2020
139
0.200
 Why?
Brazil
2
2021
175
0.200
 Why?
Cholecalciferol
1
2024
61
0.200
 Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
258
0.200
 Why?
Myelin Basic Protein
4
1998
44
0.200
 Why?
Estradiol
1
2007
538
0.200
 Why?
Orthomyxoviridae Infections
1
2004
72
0.200
 Why?
Acquired Immunodeficiency Syndrome
2
2023
230
0.200
 Why?
Maternal-Fetal Exchange
2
2016
169
0.200
 Why?
Down-Regulation
1
2025
641
0.200
 Why?
Abnormalities, Drug-Induced
1
2023
32
0.200
 Why?
Kaposi Varicelliform Eruption
3
2011
21
0.200
 Why?
Long-Term Care
1
2024
115
0.190
 Why?
Papillomavirus Infections
2
2018
354
0.190
 Why?
Antirheumatic Agents
1
2026
303
0.190
 Why?
Adenoviridae Infections
1
2023
20
0.190
 Why?
Heart Transplantation
10
2001
733
0.190
 Why?
Isoxazoles
2
2013
53
0.190
 Why?
Diabetes Mellitus, Type 1
4
2013
3838
0.190
 Why?
Liver Failure, Acute
1
2023
54
0.180
 Why?
Zidovudine
2
2015
77
0.180
 Why?
Lamivudine
2
2015
64
0.180
 Why?
Herpes Genitalis
2
2012
18
0.180
 Why?
HIV Integrase Inhibitors
1
2023
76
0.180
 Why?
United States
9
2024
15602
0.180
 Why?
Risk Factors
18
2024
10623
0.180
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2013
98
0.180
 Why?
Genes, Immediate-Early
1
2002
26
0.180
 Why?
South Africa
6
2020
221
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Genes, Viral
1
2002
92
0.180
 Why?
Central Nervous System Diseases
1
2002
75
0.180
 Why?
Antigens, Differentiation
1
2001
78
0.180
 Why?
Biliary Atresia
1
2023
144
0.180
 Why?
Tuberculin Test
1
2021
36
0.180
 Why?
Cytotoxicity, Immunologic
2
2002
226
0.180
 Why?
Interferon-gamma Release Tests
1
2021
33
0.170
 Why?
Organ Transplantation
1
2024
247
0.170
 Why?
Cells, Cultured
11
2010
4172
0.170
 Why?
Phenotype
7
2009
3183
0.170
 Why?
Treatment Outcome
17
2026
11459
0.170
 Why?
Atazanavir Sulfate
2
2023
42
0.170
 Why?
Maternal Exposure
1
2023
211
0.170
 Why?
Medication Therapy Management
1
2021
72
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
78
0.170
 Why?
Immunoglobulins
2
2017
163
0.160
 Why?
Virus Activation
3
2013
92
0.160
 Why?
Evolution, Molecular
1
2005
511
0.160
 Why?
Receptors, Immunologic
2
2000
207
0.160
 Why?
North America
2
2023
309
0.160
 Why?
Sensitivity and Specificity
5
2009
1984
0.160
 Why?
HIV Seronegativity
1
2020
30
0.160
 Why?
Histocompatibility Antigens Class I
1
2002
208
0.160
 Why?
Virus Cultivation
3
2005
31
0.160
 Why?
RNA, Ribosomal, 16S
1
2022
561
0.160
 Why?
Dietary Supplements
1
2024
576
0.150
 Why?
Heart-Assist Devices
8
2000
562
0.150
 Why?
T-Cell Antigen Receptor Specificity
1
2019
52
0.150
 Why?
Interleukin-2 Receptor alpha Subunit
1
2019
79
0.150
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
2017
13
0.150
 Why?
Eicosanoids
1
2019
58
0.150
 Why?
Survival Analysis
6
2018
1358
0.150
 Why?
Dose-Response Relationship, Immunologic
2
2016
77
0.140
 Why?
Cholera Toxin
1
2018
30
0.140
 Why?
Arthritis, Rheumatoid
2
2026
1170
0.140
 Why?
Postoperative Complications
14
2001
2894
0.140
 Why?
Hospitals
1
2023
695
0.140
 Why?
Saliva
2
2010
248
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
74
0.140
 Why?
Genotype
6
2020
1837
0.140
 Why?
Delayed-Action Preparations
2
2016
183
0.140
 Why?
Latin America
1
2018
91
0.140
 Why?
Cell Movement
2
2001
973
0.140
 Why?
Neurodevelopmental Disorders
1
2021
226
0.130
 Why?
CD4-CD8 Ratio
2
2008
24
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Vaccination Coverage
1
2018
102
0.130
 Why?
Injections, Intradermal
1
2017
11
0.130
 Why?
Cell Line
5
2009
2906
0.130
 Why?
Coronary Artery Bypass
4
2001
259
0.130
 Why?
Injections, Subcutaneous
2
2016
164
0.130
 Why?
Paralysis
1
2017
67
0.130
 Why?
Nervous System Diseases
1
2020
280
0.130
 Why?
Arm
1
2017
109
0.130
 Why?
Placenta
2
2021
778
0.120
 Why?
Seroconversion
1
2017
50
0.120
 Why?
Africa
1
2017
113
0.120
 Why?
Kinetics
3
2010
1622
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Animals
24
2011
38140
0.120
 Why?
Clinical Trials as Topic
2
2019
1047
0.120
 Why?
Adoptive Transfer
3
2002
219
0.120
 Why?
Seizures
1
2020
454
0.120
 Why?
Cross Reactions
2
2014
134
0.120
 Why?
Base Sequence
6
2017
2186
0.120
 Why?
Demography
2
2018
289
0.120
 Why?
Liver Transplantation
1
2023
781
0.120
 Why?
Colorado
2
2023
4578
0.120
 Why?
Comorbidity
2
2019
1638
0.110
 Why?
Aging
3
2017
1968
0.110
 Why?
Nevirapine
1
2015
18
0.110
 Why?
RNA
1
2022
940
0.110
 Why?
Contraceptives, Oral, Synthetic
1
2015
1
0.110
 Why?
Nasopharynx
1
2015
73
0.110
 Why?
Nasal Lavage Fluid
2
2005
15
0.110
 Why?
Immunoenzyme Techniques
2
2006
200
0.110
 Why?
Skin Diseases
1
2016
149
0.110
 Why?
Virus Latency
2
2013
87
0.110
 Why?
Infant, Newborn, Diseases
1
2016
114
0.110
 Why?
Neutropenia
1
2015
155
0.110
 Why?
Multivariate Analysis
5
2017
1508
0.110
 Why?
Seroepidemiologic Studies
2
2024
174
0.110
 Why?
Transcription, Genetic
1
2021
1504
0.110
 Why?
Computational Biology
1
2019
683
0.100
 Why?
Antigens, Differentiation, T-Lymphocyte
1
1994
102
0.100
 Why?
Pandemics
2
2021
1675
0.100
 Why?
Graft Rejection
5
2001
536
0.100
 Why?
Physical Fitness
1
2015
208
0.100
 Why?
Herpesvirus 8, Human
2
2005
67
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
9
0.100
 Why?
Anemia
1
2015
180
0.100
 Why?
Feces
1
2017
506
0.100
 Why?
Progesterone
2
2015
255
0.100
 Why?
Thrombocytopenia
1
2015
208
0.100
 Why?
Anesthesiology
1
2016
169
0.100
 Why?
Leukocyte Common Antigens
2
2009
87
0.100
 Why?
Polyomavirus Infections
1
2013
30
0.100
 Why?
Tumor Virus Infections
1
2013
50
0.100
 Why?
Epitopes
2
2009
490
0.100
 Why?
Epitopes, T-Lymphocyte
1
2014
185
0.100
 Why?
OX40 Ligand
4
2001
10
0.090
 Why?
Mothers
1
2019
769
0.090
 Why?
Transcriptome
1
2019
1047
0.090
 Why?
Proctitis
1
2012
7
0.090
 Why?
Oxadiazoles
1
2012
36
0.090
 Why?
HIV Seropositivity
1
2013
118
0.090
 Why?
Rats, Inbred Lew
4
1998
104
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
Aprotinin
3
1997
11
0.090
 Why?
DNA Primase
1
2012
47
0.090
 Why?
Oxidative Stress
1
2019
1377
0.090
 Why?
Communicable Diseases
1
2014
162
0.090
 Why?
Depression
1
2021
1520
0.090
 Why?
Mycophenolic Acid
1
2012
120
0.090
 Why?
Fluorescent Antibody Technique, Direct
1
2011
9
0.090
 Why?
Viral Plaque Assay
3
2006
32
0.090
 Why?
L-Selectin
2
2009
27
0.090
 Why?
Receptors, Interleukin-2
2
1990
64
0.080
 Why?
Histocompatibility Testing
3
2001
121
0.080
 Why?
CD8 Antigens
1
2011
74
0.080
 Why?
Encephalitis, Viral
2
2020
45
0.080
 Why?
Ribavirin
1
2011
71
0.080
 Why?
Guanine
3
2006
86
0.080
 Why?
Immunization Schedule
3
2020
187
0.080
 Why?
DNA Helicases
1
2012
145
0.080
 Why?
Fluorescent Antibody Technique
2
2016
376
0.080
 Why?
Motor Activity
1
2015
722
0.080
 Why?
Parturition
1
2011
67
0.080
 Why?
Logistic Models
5
2010
2095
0.080
 Why?
Predictive Value of Tests
3
2005
2097
0.080
 Why?
Length of Stay
3
2014
1312
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Menstrual Cycle
1
2011
140
0.080
 Why?
Algorithms
3
2021
1843
0.080
 Why?
Granzymes
1
2009
50
0.080
 Why?
Herpes Simplex Virus Vaccines
1
2009
4
0.080
 Why?
Immune System
2
2008
182
0.080
 Why?
Pokeweed Mitogens
1
2009
7
0.080
 Why?
Human Experimentation
1
2009
13
0.080
 Why?
Neuralgia, Postherpetic
1
2009
39
0.080
 Why?
Pilot Projects
2
2026
1851
0.070
 Why?
Immunologic Factors
1
2011
256
0.070
 Why?
Drug Stability
1
2009
165
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
188
0.070
 Why?
Plasma
2
2018
227
0.070
 Why?
Gene Rearrangement, T-Lymphocyte
1
2008
16
0.070
 Why?
Tumor Necrosis Factor-alpha
1
2014
1223
0.070
 Why?
Cost of Illness
1
2011
320
0.070
 Why?
Nasal Mucosa
1
2009
111
0.070
 Why?
Inflammation Mediators
1
2011
511
0.070
 Why?
Mice
13
2011
18421
0.070
 Why?
Enzyme Inhibitors
1
2012
832
0.070
 Why?
Botswana
2
2019
9
0.070
 Why?
Betaherpesvirinae
1
2008
1
0.070
 Why?
Infant Mortality
2
2019
123
0.070
 Why?
Genetic Variation
2
2011
990
0.070
 Why?
Administration, Intranasal
1
2008
93
0.070
 Why?
Exodeoxyribonucleases
1
2008
28
0.070
 Why?
Cyclosporine
2
2001
264
0.070
 Why?
Interleukin-15
1
2008
99
0.070
 Why?
Interleukin-12
1
2008
121
0.070
 Why?
Rats
5
1998
5609
0.070
 Why?
Trypan Blue
1
2007
5
0.070
 Why?
Sarcoma
1
2010
203
0.070
 Why?
Didanosine
1
2007
13
0.070
 Why?
Thymus Gland
1
2008
317
0.070
 Why?
Gene Expression
3
2006
1512
0.070
 Why?
In Vitro Techniques
3
2006
1054
0.060
 Why?
Data Interpretation, Statistical
1
2009
371
0.060
 Why?
Quality Control
1
2007
165
0.060
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2010
293
0.060
 Why?
Inhibitory Concentration 50
1
2006
93
0.060
 Why?
Vero Cells
1
2006
87
0.060
 Why?
Cerebrospinal Fluid
2
2004
92
0.060
 Why?
Pneumonia
1
2013
641
0.060
 Why?
Transfection
3
2002
952
0.060
 Why?
Drug Interactions
2
2020
398
0.060
 Why?
Multicenter Studies as Topic
2
2006
394
0.060
 Why?
Randomized Controlled Trials as Topic
2
2011
1688
0.060
 Why?
Veterans
1
2018
1586
0.060
 Why?
Antibodies, Monoclonal, Humanized
1
2012
982
0.060
 Why?
Deoxycytidine
1
2007
218
0.060
 Why?
Opportunistic Infections
2
2014
44
0.060
 Why?
Protein Structure, Tertiary
1
2008
857
0.060
 Why?
Hemostatics
2
1997
60
0.060
 Why?
Risk Assessment
2
2014
3556
0.060
 Why?
Hemadsorption
1
2005
1
0.060
 Why?
Cytopathogenic Effect, Viral
1
2005
16
0.060
 Why?
Tumor Necrosis Factors
3
2001
10
0.060
 Why?
Disease Models, Animal
2
2011
4553
0.060
 Why?
Evaluation Studies as Topic
1
2005
169
0.060
 Why?
Signal Transduction
2
2000
5241
0.060
 Why?
Gene Products, pol
1
2005
6
0.060
 Why?
Annexin A5
1
2004
22
0.060
 Why?
Clinical Trials, Phase II as Topic
2
2017
78
0.060
 Why?
Cysteine Proteinase Inhibitors
1
2004
50
0.050
 Why?
Antigens
2
2008
349
0.050
 Why?
Meningitis, Viral
1
2004
20
0.050
 Why?
Pharmacogenetics
1
2026
170
0.050
 Why?
Parainfluenza Virus 2, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 1, Human
1
2004
3
0.050
 Why?
Parainfluenza Virus 3, Human
1
2004
5
0.050
 Why?
Measles virus
1
2024
21
0.050
 Why?
Sarcoma, Kaposi
2
2003
83
0.050
 Why?
Transplantation, Homologous
2
2002
414
0.050
 Why?
Disease Transmission, Infectious
1
2005
68
0.050
 Why?
Adenoviruses, Human
1
2004
27
0.050
 Why?
Emtricitabine
2
2021
205
0.050
 Why?
Fatal Outcome
1
2005
306
0.050
 Why?
Cell Culture Techniques
1
2006
379
0.050
 Why?
Chlamydophila Infections
1
2003
5
0.050
 Why?
Chlamydophila pneumoniae
1
2003
12
0.050
 Why?
Measles
1
2024
46
0.050
 Why?
HLA-DR Antigens
3
2001
219
0.050
 Why?
Survival Rate
8
2001
2034
0.050
 Why?
Rilpivirine
1
2023
10
0.050
 Why?
Immunotherapy, Adoptive
2
2001
381
0.050
 Why?
Arteriosclerosis
1
2003
83
0.050
 Why?
Portoenterostomy, Hepatic
1
2023
39
0.050
 Why?
Hospital Mortality
4
2001
975
0.050
 Why?
Bronchiolitis Obliterans
2
2001
66
0.050
 Why?
Darunavir
1
2023
20
0.050
 Why?
Herpes Labialis
1
2003
8
0.050
 Why?
Leukemia, Myeloid, Acute
1
2010
674
0.050
 Why?
Cell Line, Tumor
1
2011
3609
0.050
 Why?
DNA Primers
3
2009
516
0.050
 Why?
Respirovirus
1
2002
6
0.050
 Why?
Pregnancy Trimester, First
1
2023
135
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
2
1994
335
0.050
 Why?
Risk
1
2005
901
0.050
 Why?
Bronchoalveolar Lavage Fluid
1
2005
644
0.050
 Why?
Parapsychology
1
2001
1
0.050
 Why?
Adenoviridae
1
2023
203
0.050
 Why?
Electromagnetic Fields
1
2001
37
0.040
 Why?
Zimbabwe
2
2017
67
0.040
 Why?
B7-1 Antigen
2
1998
55
0.040
 Why?
Microbial Sensitivity Tests
1
2003
371
0.040
 Why?
Ovalbumin
1
2001
194
0.040
 Why?
Molecular Sequence Data
4
1994
2914
0.040
 Why?
Liver Diseases
1
2024
277
0.040
 Why?
Cobicistat
1
2021
5
0.040
 Why?
Receptors, CXCR5
1
2021
27
0.040
 Why?
Antibody Affinity
1
2021
60
0.040
 Why?
Photography
1
2001
114
0.040
 Why?
Rituximab
2
2013
210
0.040
 Why?
CTLA-4 Antigen
1
2001
107
0.040
 Why?
Immunoglobulins, Intravenous
1
2002
128
0.040
 Why?
Vaccines, Subunit
1
2021
52
0.040
 Why?
Prostheses and Implants
3
1996
141
0.040
 Why?
Lymphoma
1
2002
234
0.040
 Why?
Arylamine N-Acetyltransferase
1
2020
8
0.040
 Why?
Cytochrome P-450 CYP2B6
1
2020
10
0.040
 Why?
Gene Expression Regulation
1
1990
2620
0.040
 Why?
Equivalence Trials as Topic
1
2020
35
0.040
 Why?
Pre-Eclampsia
1
2023
203
0.040
 Why?
Analysis of Variance
2
2016
1308
0.040
 Why?
Models, Statistical
1
2005
680
0.040
 Why?
Sentinel Lymph Node Biopsy
1
2001
120
0.040
 Why?
Metabolic Clearance Rate
1
2020
116
0.040
 Why?
Living Donors
1
2023
276
0.040
 Why?
Glioma
1
2005
424
0.040
 Why?
DNA
2
2006
1427
0.040
 Why?
Surface Properties
1
2001
411
0.040
 Why?
Spinal Cord
2
1994
381
0.040
 Why?
Central Nervous System Neoplasms
1
2002
172
0.040
 Why?
Heart Failure
3
1999
2175
0.040
 Why?
Trans-Activators
1
2002
398
0.040
 Why?
Lymphatic Metastasis
1
2001
333
0.040
 Why?
Confusion
1
2020
30
0.040
 Why?
Alanine
1
2021
168
0.040
 Why?
Cancer Vaccines
1
2001
167
0.040
 Why?
Hemodynamics
3
2001
1116
0.040
 Why?
Coronary Disease
2
2001
369
0.040
 Why?
Antibodies
1
2001
399
0.040
 Why?
Interleukin-3
3
1994
23
0.040
 Why?
Liver Function Tests
1
2019
99
0.040
 Why?
California
2
2015
464
0.040
 Why?
Candidiasis
1
1999
64
0.040
 Why?
Triiodothyronine
1
1999
49
0.040
 Why?
Prognosis
3
2024
4210
0.040
 Why?
Recombinant Fusion Proteins
2
1999
683
0.040
 Why?
Infant, Very Low Birth Weight
1
2019
75
0.040
 Why?
Hemagglutination
1
2018
7
0.040
 Why?
Macrophage-1 Antigen
1
1999
26
0.040
 Why?
Hypoplastic Left Heart Syndrome
1
2000
120
0.040
 Why?
Tenofovir
1
2021
293
0.040
 Why?
Arginine Vasopressin
1
1998
44
0.040
 Why?
Cross-Sectional Studies
3
2024
5761
0.040
 Why?
Mice, Inbred BALB C
1
2001
1270
0.040
 Why?
Polymorphism, Single Nucleotide
3
2011
2167
0.040
 Why?
Brain Diseases
1
2020
152
0.040
 Why?
Adenine
1
2021
333
0.030
 Why?
Neoplasms
3
2001
2902
0.030
 Why?
HLA-B Antigens
1
1998
57
0.030
 Why?
Haptoglobins
1
2018
65
0.030
 Why?
Vasoconstrictor Agents
1
1998
144
0.030
 Why?
Chronic Disease
1
2024
1826
0.030
 Why?
Delivery, Obstetric
1
2019
161
0.030
 Why?
Antibody Specificity
1
1998
185
0.030
 Why?
Immunization
1
2020
375
0.030
 Why?
Protein Precursors
1
2018
135
0.030
 Why?
Clinical Trials, Phase I as Topic
1
2017
52
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Shock
1
1998
109
0.030
 Why?
Autogenic Training
1
1997
1
0.030
 Why?
Proviruses
1
2017
16
0.030
 Why?
Radioactive Fallout
1
1997
1
0.030
 Why?
Product Surveillance, Postmarketing
1
2017
68
0.030
 Why?
Leukemia, Radiation-Induced
1
1997
4
0.030
 Why?
Radioactive Hazard Release
1
1997
5
0.030
 Why?
Sequence Analysis
1
2017
35
0.030
 Why?
Observational Studies as Topic
1
2017
127
0.030
 Why?
Power Plants
1
1997
10
0.030
 Why?
Relaxation Therapy
1
1997
19
0.030
 Why?
Zambia
1
2017
56
0.030
 Why?
Tanzania
1
2017
60
0.030
 Why?
Reproducibility of Results
1
2005
3392
0.030
 Why?
Encephalitis
1
1998
139
0.030
 Why?
Lung Injury
1
2000
227
0.030
 Why?
Ligands
1
1999
674
0.030
 Why?
Heart Valves
1
1997
42
0.030
 Why?
Aortic Valve Insufficiency
1
1996
44
0.030
 Why?
Prevalence
2
2018
2819
0.030
 Why?
Erythema
1
2016
28
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2016
29
0.030
 Why?
Neoplasms, Radiation-Induced
1
1997
98
0.030
 Why?
Body Weight
1
2020
993
0.030
 Why?
Up-Regulation
2
2001
863
0.030
 Why?
Fiber Optic Technology
1
2016
24
0.030
 Why?
Heart Arrest, Induced
1
1995
34
0.030
 Why?
Chi-Square Distribution
2
2013
516
0.030
 Why?
Thromboembolism
1
1996
124
0.030
 Why?
Graft vs Host Disease
1
1998
265
0.030
 Why?
Intestines
1
2018
354
0.030
 Why?
Vasodilation
1
1998
522
0.030
 Why?
Reference Values
2
2011
806
0.030
 Why?
DNA-Binding Proteins
1
2002
1493
0.030
 Why?
Interleukin-4
2
1998
212
0.030
 Why?
Single-Blind Method
1
2016
308
0.030
 Why?
Blood Transfusion
2
1995
405
0.030
 Why?
Registries
1
2024
2242
0.030
 Why?
Ovulation
1
2015
41
0.030
 Why?
Hematologic Neoplasms
1
1997
162
0.030
 Why?
Antibodies, Monoclonal
2
2001
1522
0.030
 Why?
Liver
1
2023
1846
0.030
 Why?
Cross Infection
1
1997
260
0.030
 Why?
Gene Regulatory Networks
1
2017
322
0.030
 Why?
Hypothermia, Induced
1
1995
95
0.030
 Why?
Rats, Inbred BUF
1
1994
1
0.030
 Why?
Blood Loss, Surgical
1
1995
112
0.030
 Why?
HLA-A2 Antigen
1
2014
47
0.030
 Why?
Surgical Wound Infection
1
1997
327
0.030
 Why?
Aortic Coarctation
1
1994
79
0.030
 Why?
Polymorphism, Restriction Fragment Length
2
2003
65
0.030
 Why?
Pulmonary Emphysema
1
1996
310
0.030
 Why?
Myocardial Infarction
1
2001
1084
0.020
 Why?
Colony-Stimulating Factors
2
1990
37
0.020
 Why?
Cross-Over Studies
1
2016
594
0.020
 Why?
Aortic Valve
1
1996
360
0.020
 Why?
Quality of Life
4
2000
3142
0.020
 Why?
BK Virus
1
2013
17
0.020
 Why?
Cause of Death
3
2001
461
0.020
 Why?
Growth Substances
2
1990
141
0.020
 Why?
JC Virus
1
2013
23
0.020
 Why?
Intubation, Intratracheal
1
2016
310
0.020
 Why?
Herpesviridae
1
2012
22
0.020
 Why?
Mice, Inbred Strains
2
1990
399
0.020
 Why?
Drug Administration Schedule
2
2007
779
0.020
 Why?
Genetic Predisposition to Disease
2
2011
2407
0.020
 Why?
Cardiac Surgical Procedures
1
1998
597
0.020
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
1990
152
0.020
 Why?
Hypersensitivity, Delayed
1
1992
29
0.020
 Why?
Brain Neoplasms
1
2001
1307
0.020
 Why?
Ventricular Function, Left
1
1995
522
0.020
 Why?
Heart Diseases
1
1995
343
0.020
 Why?
Spleen
1
1994
517
0.020
 Why?
Kaplan-Meier Estimate
1
2014
957
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2001
1938
0.020
 Why?
Ambulatory Care
1
1996
592
0.020
 Why?
Histocompatibility Antigens
1
1992
103
0.020
 Why?
Sex Characteristics
1
2017
786
0.020
 Why?
Patient Selection
1
1995
695
0.020
 Why?
Metabolomics
1
2017
721
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Computer Simulation
1
2016
1032
0.020
 Why?
Kidney Failure, Chronic
1
1997
596
0.020
 Why?
Receptors, Interferon
1
2011
59
0.020
 Why?
Age of Onset
1
2012
543
0.020
 Why?
Stroke
1
2000
1219
0.020
 Why?
Administration, Oral
1
2013
841
0.020
 Why?
Cattle
2
1990
1004
0.020
 Why?
Radiotherapy
2
2005
208
0.020
 Why?
Polyribosomes
1
1990
22
0.020
 Why?
Cell Separation
1
2011
311
0.020
 Why?
Lung Neoplasms
2
2001
2636
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1990
157
0.020
 Why?
Concanavalin A
1
1990
71
0.020
 Why?
Tetradecanoylphorbol Acetate
1
1990
153
0.020
 Why?
Regulatory Sequences, Nucleic Acid
1
1990
97
0.020
 Why?
Blotting, Northern
1
1990
202
0.020
 Why?
Haplotypes
1
2011
490
0.020
 Why?
Papillomaviridae
1
2010
121
0.020
 Why?
Genetic Association Studies
1
2011
375
0.020
 Why?
Infant, Premature
1
2014
611
0.020
 Why?
Practice Guidelines as Topic
1
2017
1525
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
Cell Division
2
2002
780
0.020
 Why?
Herpesvirus 1, Bovine
1
1989
3
0.020
 Why?
Mice, Knockout
2
2011
3120
0.020
 Why?
Anxiety
1
1997
1100
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
667
0.020
 Why?
Immunoglobulin E
1
2010
318
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
765
0.020
 Why?
Hematopoietic Stem Cells
2
1990
418
0.020
 Why?
Reference Standards
1
2009
181
0.020
 Why?
Ribosomes
1
1990
191
0.020
 Why?
Phylogeny
1
2013
1011
0.020
 Why?
Multiple Sclerosis
1
1994
482
0.020
 Why?
Linear Models
1
2010
857
0.020
 Why?
Infusions, Intravenous
2
1999
427
0.020
 Why?
Clinical Competence
1
2016
1226
0.020
 Why?
Membrane Proteins
1
1994
1182
0.020
 Why?
Time
1
2007
88
0.020
 Why?
Protein Biosynthesis
1
1990
454
0.020
 Why?
Drug Resistance, Multiple
1
2006
25
0.020
 Why?
Kidney Transplantation
1
2013
693
0.020
 Why?
Antineoplastic Agents
2
2010
2220
0.020
 Why?
Clinical Protocols
1
2007
280
0.010
 Why?
Templates, Genetic
1
2005
62
0.010
 Why?
Postoperative Care
2
1999
278
0.010
 Why?
Cell Differentiation
4
2000
2045
0.010
 Why?
Codon
1
2005
94
0.010
 Why?
Internship and Residency
1
2016
1245
0.010
 Why?
Interleukin-5
2
1998
44
0.010
 Why?
Diagnosis, Differential
1
2009
1502
0.010
 Why?
DNA Replication
1
2006
258
0.010
 Why?
Mice, Transgenic
2
2000
2182
0.010
 Why?
Age Distribution
1
2005
395
0.010
 Why?
Sex Distribution
1
2005
379
0.010
 Why?
Vaccines
1
2009
387
0.010
 Why?
Creatinine
2
1997
492
0.010
 Why?
Abdominal Neoplasms
1
2003
47
0.010
 Why?
Lung
1
1996
4143
0.010
 Why?
Endemic Diseases
1
2003
33
0.010
 Why?
Disease Progression
1
2010
2871
0.010
 Why?
Peptide Fragments
2
1998
706
0.010
 Why?
Sequence Analysis, DNA
1
2005
828
0.010
 Why?
Bioelectric Energy Sources
1
2001
4
0.010
 Why?
Neuroblastoma
1
2003
168
0.010
 Why?
Fibrosarcoma
1
2001
23
0.010
 Why?
Galvanic Skin Response
1
2001
26
0.010
 Why?
Electricity
1
2001
26
0.010
 Why?
Electric Conductivity
1
2001
84
0.010
 Why?
Actuarial Analysis
1
2001
22
0.010
 Why?
Injections, Intravenous
1
2001
200
0.010
 Why?
Melanoma, Experimental
1
2001
112
0.010
 Why?
Fingers
1
2001
107
0.010
 Why?
HLA-A Antigens
1
2001
54
0.010
 Why?
Myocardial Revascularization
1
2001
75
0.010
 Why?
Anticoagulants
2
1996
718
0.010
 Why?
Statistics, Nonparametric
1
2001
431
0.010
 Why?
Muscle, Smooth, Vascular
1
2003
450
0.010
 Why?
Immune Sera
1
2000
76
0.010
 Why?
Amino Acid Sequence
2
1994
2148
0.010
 Why?
Probability
1
2001
305
0.010
 Why?
Clone Cells
1
2000
269
0.010
 Why?
Mice, Inbred C57BL
2
2001
6032
0.010
 Why?
Emergency Treatment
1
2001
125
0.010
 Why?
Databases as Topic
1
2000
68
0.010
 Why?
New York
1
2000
125
0.010
 Why?
Lymphocytes, Tumor-Infiltrating
1
2001
219
0.010
 Why?
Carotid Artery Diseases
1
2000
68
0.010
 Why?
Students
1
2005
667
0.010
 Why?
Peripheral Vascular Diseases
1
2000
103
0.010
 Why?
Columbidae
1
1998
31
0.010
 Why?
Cytochrome c Group
1
1998
42
0.010
 Why?
Cardiotonic Agents
1
1999
94
0.010
 Why?
Lymph Nodes
1
2001
502
0.010
 Why?
Cardiac Output
1
1999
179
0.010
 Why?
Life Tables
1
1998
20
0.010
 Why?
Endocardium
1
1998
31
0.010
 Why?
Temperature
1
2001
681
0.010
 Why?
Aortic Diseases
1
2000
123
0.010
 Why?
Vascular Resistance
1
1999
366
0.010
 Why?
Calcinosis
1
2000
235
0.010
 Why?
Cell Death
1
1999
387
0.010
 Why?
Renal Insufficiency
1
2000
167
0.010
 Why?
Hypotension
1
1998
127
0.010
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
1998
193
0.010
 Why?
Cardiopulmonary Bypass
1
2000
220
0.010
 Why?
Phosphorylation
1
2002
1761
0.010
 Why?
Ukraine
1
1997
22
0.010
 Why?
Odds Ratio
1
2000
1057
0.010
 Why?
Endocarditis, Bacterial
1
1997
45
0.010
 Why?
Dose-Response Relationship, Drug
1
2001
2030
0.010
 Why?
Models, Structural
1
1996
40
0.010
 Why?
Lung Volume Measurements
1
1996
46
0.010
 Why?
Radiometry
1
1997
55
0.010
 Why?
Histocompatibility Antigens Class II
1
1998
366
0.010
 Why?
Epidemiologic Methods
1
1997
92
0.010
 Why?
Ultrasonography, Doppler, Transcranial
1
1996
46
0.010
 Why?
Health Care Costs
1
2000
416
0.010
 Why?
Cardiac Output, Low
1
1996
48
0.010
 Why?
Equipment Failure
1
1996
112
0.010
 Why?
Urogenital Neoplasms
1
1995
5
0.010
 Why?
Europe
1
1997
410
0.010
 Why?
Vital Capacity
1
1996
311
0.010
 Why?
Neoplasms, Second Primary
1
1997
102
0.010
 Why?
Pneumonia, Viral
1
2001
385
0.010
 Why?
Blood Urea Nitrogen
1
1995
52
0.010
 Why?
Models, Cardiovascular
1
1996
197
0.010
 Why?
Forced Expiratory Volume
1
1996
493
0.010
 Why?
Heart Valve Prosthesis
1
1997
124
0.010
 Why?
Acute Disease
1
1998
996
0.010
 Why?
Aortic Aneurysm
1
1995
70
0.010
 Why?
Heart Rate
1
1999
843
0.010
 Why?
Child Development
1
2000
494
0.010
 Why?
Biopsy
1
1998
1068
0.010
 Why?
Equipment Design
1
1996
534
0.010
 Why?
Hodgkin Disease
1
1997
167
0.010
 Why?
Proportional Hazards Models
1
1998
1305
0.010
 Why?
Waiting Lists
1
1996
260
0.010
 Why?
Receptors, Antigen, T-Cell
1
1998
726
0.010
 Why?
Heart Septal Defects, Ventricular
1
1994
46
0.010
 Why?
Reoperation
1
1997
602
0.010
 Why?
Interviews as Topic
1
1997
884
0.010
 Why?
Exercise Test
1
1996
621
0.010
 Why?
Cell Adhesion
1
1994
457
0.010
 Why?
Myocardium
1
1998
946
0.010
 Why?
Thyroid Neoplasms
1
1997
346
0.010
 Why?
Ventricular Function, Right
1
1995
296
0.010
 Why?
Central Nervous System
1
1994
272
0.010
 Why?
Smoking
1
2000
1556
0.010
 Why?
Patient Compliance
1
1997
612
0.010
 Why?
Feasibility Studies
1
1996
1065
0.010
 Why?
Blood Pressure
1
1998
1751
0.010
 Why?
Diabetes Mellitus
1
2000
1088
0.010
 Why?
Head and Neck Neoplasms
1
1995
560
0.010
 Why?
Research Design
1
1997
1121
0.010
 Why?
Lymphocyte Cooperation
1
1990
50
0.000
 Why?
Receptors, Lymphocyte Homing
1
1990
15
0.000
 Why?
Thymectomy
1
1990
15
0.000
 Why?
Antilymphocyte Serum
1
1990
61
0.000
 Why?
Antigens, Surface
1
1990
156
0.000
 Why?
Rabbits
1
1990
656
0.000
 Why?
Infectious Bovine Rhinotracheitis
1
1989
1
0.000
 Why?
Phorbol Esters
1
1989
14
0.000
 Why?
Ionomycin
1
1989
22
0.000
 Why?
Ethers
1
1989
19
0.000
 Why?
Kidney
1
1997
1483
0.000
 Why?
Isoantigens
1
1988
17
0.000
 Why?
Immunotherapy
1
1994
669
0.000
 Why?
Cell-Free System
1
1988
53
0.000
 Why?
Surveys and Questionnaires
1
2000
6004
0.000
 Why?
Breast Neoplasms
1
1997
2497
0.000
 Why?
Models, Biological
1
1988
1833
0.000
 Why?
Weinberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (834) concept(s)
_
Co-Authors Expand Description
See all (67) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)